chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Off label use, Product use issue, Urticaria
Clinical narrative: Hives on right and left leg; off label use; other vaccine same date vaccine date 13Sep2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 13Sep2021 12:00 (Lot number: FC3182) at the age of 46 years as dose 2, single for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), administered in arm left, administration date 13Sep2021 (Batch/Lot number: unknown) as dose 1, single for immunisation. Relevant medical history included: "Depression" (unspecified if ongoing); "Generalized Anxiety" (unspecified if ongoing); "ADD" (unspecified if ongoing). Concomitant medication(s) included: FLUOXETINE; ADDERALL; SPIRONOLACTONE. Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer, lot number=FC3180, administration date=18Aug2021, administration time=10:00 AM, dose number=1, vaccine location=Left arm), administration date: 18Aug2021, when the patient was 46 years old, for Covid-19 immunization. The following information was reported: OFF LABEL USE (non-serious) with onset 13Sep2021, outcome "unknown", described as "off label use"; PRODUCT USE ISSUE (non-serious) with onset 13Sep2021, outcome "unknown", described as "other vaccine same date vaccine date 13Sep2021"; URTICARIA (non-serious) with onset 13Sep2021 16:00, outcome "not recovered", described as "Hives on right and left leg". Therapeutic measures were not taken as a result of urticaria.  Additional information: The patient had no known allergies. The patient received other vaccine on the same day of Pfizer vaccine. Hives on right and left leg about 4 hours post injection. Facility type vaccine was Pharmacy or Drug Store. The patient took other medication in two weeks. The patient did not receive any other vaccine four weeks. The patient had no covid prior vaccination, and had not been tested for covid post vaccination.   No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, SARS-CoV-2 test, Throat irritation
Clinical narrative: itchiness and mild swelling in my throat; itchiness and mild swelling in my throat; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient (not pregnant) received bnt162b2 (COMIRNATY), administered in arm left, administration date 06Aug2021 11:45 (Lot number: FC3181) at the age of 36 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "known allergies: Penicillin" (unspecified if ongoing), notes: known allergies: Penicillin; "known allergies: latex" (unspecified if ongoing), notes: known allergies: latex. There were no concomitant medications. The following information was reported: THROAT IRRITATION (non-serious), PHARYNGEAL SWELLING (non-serious) all with onset Aug2021, outcome "recovered" (2021) and all described as "itchiness and mild swelling in my throat". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of throat irritation, pharyngeal swelling.  Additional information-Patient had COVID-19 vaccine at Pharmacy or Drug Store. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other medications the patient received within 2 weeks of vaccination. Patient was advised to take Benadryl for the AE. Patient was not diagnosed with COVID-19 prior to vaccination. Patient was tested for COVID-19 since the vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Swelling, Taste disorder
Clinical narrative: blinding headache; Neck swelling - warm; taste buds affected adversely; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Sep2021 (Lot number: FC3183) at the age of 58 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Inflammatory arthritis" (unspecified if ongoing). Concomitant medication(s) included: METHOTREXATE; HUMIRA. The following information was reported: HEADACHE (non-serious) with onset 11Sep2021, outcome "recovering", described as "blinding headache"; SWELLING (non-serious) with onset 11Sep2021, outcome "recovering", described as "Neck swelling - warm"; TASTE DISORDER (non-serious) with onset 11Sep2021, outcome "recovering", described as "taste buds affected adversely". Therapeutic measures were not taken as a result of headache, swelling, taste disorder.  Additional Information: Neck swelling warm, taste buds affected adversely, blinding headache in middle of night, rheumatoid medications not working for inflammation. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and Since the vaccination, the patient has not been tested for COVID-19. Seriousness criteria-Results in death/Seriousness criteria-Life threatening/Seriousness criteria-Caused/prolonged hospitalization/Seriousness criteria-Disabling/Incapacitating/Seriousness criteria-Congenital anomaly/birth defect all were reported as no.  No follow-up attempts are possible. No further information is expected.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching over most of body/Barely noticeable at first but by Apr it was driving me nuts; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 80 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 18Jan2021 (Lot number: EK9231) at the age of 80 years as dose 1, single and intramuscular, administered in arm left, administration date 09Feb2021 (Lot number: EL8982) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PRURITUS (non-serious) with onset 18Jan2021, outcome "not recovered", described as "Itching over most of body/Barely noticeable at first but by Apr it was driving me nuts". The event "itching over most of body/barely noticeable at first but by apr it was driving me nuts" was evaluated at the physician office visit. Therapeutic measures were taken as a result of pruritus.  Additional information: Itching over most of body. Barely noticeable at first but by Apr it was driving me nuts. The patient was being treated with Gabapentin but so far it was not working. As on 11Feb2021 (Approx Feb2021), the patient still experiencing symptoms. The patient was treated with Pregabalin. The most recent COVID-19 vaccine was administered at other facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. The adverse event result in Doctor or other healthcare professional office/clinic visit. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No known allergies. Vaccine was not administered at facility.  No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: U
Vaccine: COVID19
Symptoms: Drug hypersensitivity, Rash
Clinical narrative: Have got tons of rash; Rash on my hands and arms; allergic reaction; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old patient received bnt162b2 (BNT162B2), administration date 16Sep2021 (Lot number: EW0183) at the age of 43 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "High Blood Pressure" (unspecified if ongoing), notes: Verbatim: High Blood Pressure. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, LOT/BATCH: EW0177, Unknown manufacturer), administration date: 26Aug2021, when the patient was 43 years old, for Covid-19 immunization.  The following information was reported: RASH (non-serious), outcome "unknown", described as "Have got tons of rash; Rash on my hands and arms"; DRUG HYPERSENSITIVITY (non-serious), outcome "unknown", described as "allergic reaction".  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Body temperature, Hypoaesthesia, Illness, Lymphadenopathy
Clinical narrative: hair started falling out again like it did first shot; Numbness in both arms; ringing in ears(still have); fever 102; swollen lymph nodes; sever pain in arm that lasted for 3 months after shot; sickness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 21Apr2021 (Lot number: Ew0170) at the age of 46 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Anatomical Location: Arm left, Batch/lot number: Er8732), administration date: 23Mar2021, when the patient was 46 years old, for Covid-19 Immunisation, reaction(s): "hair started falling out", "Numbness in both arms", "ringing in ears(still have)", "sever pain in arm", "swollen lymph nodes". The following information was reported: ALOPECIA (non-serious) with onset 2021, outcome "recovering", described as "hair started falling out again like it did first shot"; HYPOAESTHESIA (non-serious) with onset 2021, outcome "recovering", described as "Numbness in both arms"; TINNITUS (non-serious) with onset 2021, outcome "recovering", described as "ringing in ears(still have)"; PYREXIA (non-serious) with onset 2021, outcome "recovering", described as "fever 102"; LYMPHADENOPATHY (non-serious) with onset 2021, outcome "recovering", described as "swollen lymph nodes"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovering", described as "sever pain in arm that lasted for 3 months after shot"; ILLNESS (non-serious) with onset 2021, outcome "recovering", described as "sickness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of alopecia, hypoaesthesia, tinnitus, pyrexia, lymphadenopathy, pain in extremity, illness.  Additional information: Patient was not pregnant at the time of vaccination. Patient had no known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Numbness in both arms that lasted about 3 months, hair started falling out again like it did first shot. Fever 102 for 24 hrs, ringing in ears(still have),swollen lymph nodes, sever pain in arm that lasted for 3 months after shot. Patient missed 5 days of work the second shot due to sickness after. Patient cried in pain for 2 days from body pain and fever. Patient's hair was still recovering. Therapeutic measures taken for the event included Chiropractor & getting messages, and salt float ta. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, SARS-CoV-2 test, Tinnitus
Clinical narrative: hair started falling out again like it did first shot; Numbness in both arms; ringing in ears(still have); fever 102; swollen lymph nodes; sever pain in arm that lasted for 3 months after shot; sickness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 21Apr2021 (Lot number: Ew0170) at the age of 46 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Anatomical Location: Arm left, Batch/lot number: Er8732), administration date: 23Mar2021, when the patient was 46 years old, for Covid-19 Immunisation, reaction(s): "hair started falling out", "Numbness in both arms", "ringing in ears(still have)", "sever pain in arm", "swollen lymph nodes". The following information was reported: ALOPECIA (non-serious) with onset 2021, outcome "recovering", described as "hair started falling out again like it did first shot"; HYPOAESTHESIA (non-serious) with onset 2021, outcome "recovering", described as "Numbness in both arms"; TINNITUS (non-serious) with onset 2021, outcome "recovering", described as "ringing in ears(still have)"; PYREXIA (non-serious) with onset 2021, outcome "recovering", described as "fever 102"; LYMPHADENOPATHY (non-serious) with onset 2021, outcome "recovering", described as "swollen lymph nodes"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovering", described as "sever pain in arm that lasted for 3 months after shot"; ILLNESS (non-serious) with onset 2021, outcome "recovering", described as "sickness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of alopecia, hypoaesthesia, tinnitus, pyrexia, lymphadenopathy, pain in extremity, illness.  Additional information: Patient was not pregnant at the time of vaccination. Patient had no known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Numbness in both arms that lasted about 3 months, hair started falling out again like it did first shot. Fever 102 for 24 hrs, ringing in ears(still have),swollen lymph nodes, sever pain in arm that lasted for 3 months after shot. Patient missed 5 days of work the second shot due to sickness after. Patient cried in pain for 2 days from body pain and fever. Patient's hair was still recovering. Therapeutic measures taken for the event included Chiropractor & getting messages, and salt float ta. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Arthralgia, Arthritis, Myalgia, Red blood cell sedimentation rate
Clinical narrative: Aching muscles and joints; Aching muscles and joints; sed rate of eighty and anemia; Joint pain inflammation; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 71 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYALGIA (non-serious), ARTHRALGIA (non-serious), outcome "unknown" and all described as "Aching muscles and joints"; ANAEMIA (non-serious), outcome "unknown", described as "sed rate of eighty and anemia"; ARTHRITIS (non-serious), outcome "unknown", described as "Joint pain inflammation". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: aching muscles and joints after the first shot for a week, continued aching muscle and joint pain inflammation at sed rate of eighty and anemia after the 2nd vaccine it has been 10 weeks and she was barely able to walk. She was barely able to walk due to inflammation in my legs, she was barely move her arms due to inflammation in my shoulders, She was barely able to get into and out of the bed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Facial pain, Lymphadenopathy, Oropharyngeal pain, Swelling, Swelling face
Clinical narrative: Whole right side of jawline, cheek to neck is swollen, thinks its lymph nodes; Whole right side of jawline, cheek to neck is swollen, thinks its lymph nodes; Whole right side of jawline, cheek to neck is swollen, thinks its lymph nodes; From cheek to neck, was swollen; she thinks it is her lymph nodes. States that the area is painful.; Tonsil on right side is sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32 year-old female patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 15Sep2021 16:00 (Lot number: FF2588) at the age of 32 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset 15Sep2021, outcome "not recovered", described as "Tonsil on right side is sore"; SWELLING FACE (non-serious), SWELLING (non-serious), LYMPHADENOPATHY (non-serious) all with onset 16Sep2021, outcome "not recovered" and all described as "Whole right side of jawline, cheek to neck is swollen, thinks its lymph nodes"; FACIAL PAIN (non-serious) with onset 16Sep2021, outcome "not recovered", described as "From cheek to neck, was swollen; she thinks it is her lymph nodes. States that the area is painful".  Additional Information: The Caller states that she is calling about the Pfizer Product was Comirnaty. Caller states she was had side effects. She took the first shot on Wednesday in the afternoon at 16:00. That night her tonsil on the right side was sore. That morning she got up and her whole right side of her jawline, from cheek to neck, was swollen; she thinks it is her lymph nodes. States that the area is painful. Caller states was has been two days, she called her doctor and they suggested she call Pfizer to report her symptoms. Event Details was Caller states that her symptoms was all persisting. Caller states she does not know if she has any other medications or medical conditions relevant to these events. Any AE(s) require a visit to Emergency Room, Physician Office was No. caller States she only called her doctor and did not visit office. The patient does not receive any other vaccines within 4 weeks prior to the COVID vaccine. The AE(s) following prior vaccinations was none. History of all previous immunization with the Pfizer vaccine considered as suspect(or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) reported as none. Additional Vaccines Administered on Same Date of the Pfizer Suspect If applicable, list all vaccines administered on same date with the Pfizer vaccine considered as suspect reported as none. Family Medical History Relevant to AE(s): None. Relevant Tests: None.  No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dyspnoea, Fatigue, Headache, Hyperaesthesia
Clinical narrative: 102 fever; Sore arm at site; Muscle soreness; Skin sensitivity; Headache; Fatigue/Extremely tired; Breathless; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2) (Lot number: Fc3183) at the age of 50 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: prior to vaccination, the patient was diagnosed with COVID-19. The patient's concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "102 fever"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Sore arm at site"; MYALGIA (non-serious), outcome "unknown", described as "Muscle soreness"; HYPERAESTHESIA (non-serious), outcome "unknown", described as "Skin sensitivity"; HEADACHE (non-serious), outcome "unknown", described as "Headache"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue/Extremely tired"; DYSPNOEA (non-serious), outcome "unknown", described as "Breathless". Relevant laboratory tests and procedures are available in the appropriate section. No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: 102 fever; Sore arm at site; Muscle soreness; Skin sensitivity; Headache; Fatigue/Extremely tired; Breathless; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2) (Lot number: Fc3183) at the age of 50 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: prior to vaccination, the patient was diagnosed with COVID-19. The patient's concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "102 fever"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Sore arm at site"; MYALGIA (non-serious), outcome "unknown", described as "Muscle soreness"; HYPERAESTHESIA (non-serious), outcome "unknown", described as "Skin sensitivity"; HEADACHE (non-serious), outcome "unknown", described as "Headache"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue/Extremely tired"; DYSPNOEA (non-serious), outcome "unknown", described as "Breathless". Relevant laboratory tests and procedures are available in the appropriate section. No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: like chest pain on the first day chest pains; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHEST PAIN (non-serious), outcome "unknown", described as "like chest pain on the first day chest pains".  Additional information: it was reported that her chest pains the first day severe chest pains lasted about three minutes slight chest pain on the first day really bad chest pains that lasted about three to four minutes chest pains  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Rash; itching all over; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 92 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Jan2021 15:15 (Lot number: EL3248) at the age of 91 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Atrial fibrillation" (unspecified if ongoing). Concomitant medication(s) included: COUMADIN; LOSARTAN; BISOPRIL, stop date: 2021; HCTZ. The following information was reported: PRURITUS (non-serious) with onset 20Jan2021 20:00, outcome "not recovered", described as "itching all over"; RASH (non-serious) with onset Feb2021, outcome "not recovered", described as "Rash". The events "itching all over" and "rash" were evaluated at the physician office visit. Therapeutic measures were taken as a result of pruritus, rash.  Additional information: The patient started itching all over with no rash. The patient's itching has kept her up at night (it's the worse at night) but the patient had itch all day. After a couple of weeks, the patient got a rash; thinking it was where she would scratch. The patient went to several dermatologist and nothing. The patient got off the bisoprl; thinking that was it. The patient got the second shot and then she got the pfizer booster and the patient's daughter gave her a print out saying itching and rash were side effects of the shots. if the patient had known that; she wouldn't have taken it. The patient was so miserable. The patient tried creams from dermatologist that doesn't work. The patient was treated with creams. The patient did not receive any other vaccine within 4 weeks. The patient had the most recent COVID-19 vaccine was administered in a hospital. The adverse event resulted in Doctor or other healthcare professional office or clinic visit. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Device Date was 17Sep2021.  Follow-up attempts are completed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Haemoptysis
Clinical narrative: coughed up and a little bit red; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HAEMOPTYSIS (non-serious), outcome "unknown", described as "coughed up and a little bit red". No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia, Somnolence
Clinical narrative: low fever; bad headache; was extremely exhausted that she slept for three days; was extremely exhausted that she slept for three days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2), administration date 05Feb2021 (Lot number: EL9265) at the age of 65 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: VITAMIN D [COLECALCIFEROL]; FISH OIL; MULTIVITAMINS & MINERALS PLUS LUTEIN. The following information was reported: PYREXIA (non-serious) with onset 2021, outcome "unknown", described as "low fever"; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "bad headache"; FATIGUE (non-serious), SOMNOLENCE (non-serious) all with onset 2021, outcome "unknown" and all described as "was extremely exhausted that she slept for three days".  Additional information: The patient reported that after the first dose of the Pfizer Covid-19 vaccine, she had complaints of a low fever, very bad headache, and was extremely exhausted that she slept for three days.    No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Cough, Headache, Illness
Clinical narrative: Headache; Chills; I got so sick for 3-4 days; I threw up; I stilll have some cough; I still have some difficulty with endurance; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101409427 (Pfizer).  A 54 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 03Mar2021 (Lot number: EN6205) at the age of 54 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: 2020 (ongoing), notes: 2 scares for 4 days in Jun-Jul 2020. Fever, Chills, monstrous Headache, phlegmy cough, Rapid heart rate, Zero endurance Unable to walk 1o w/o losing breath. I used glutathione with black current syrup calcium , magnesium, with zinc, echinacea. Concomitant medication(s) included: GLUTATHIONE taken for covid-19; VITAMIN D NOS, start date: 2014 (ongoing). Vaccination history included: Bnt162b2 (First dose, Anatomical location: Upper Left arm, Lot number: Pfizer EN6201), administration date: 12Feb2021, when the patient was 54 years old, for COVID-19 immunization. The following information was reported: ILLNESS (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "I got so sick for 3-4 days"; VOMITING (non-serious) with onset 2021, outcome "unknown", described as "I threw up"; COUGH (non-serious) with onset 2021, outcome "not recovered", described as "I stilll have some cough"; ASTHENIA (non-serious) with onset 2021, outcome "unknown", described as "I still have some difficulty with endurance"; HEADACHE (non-serious) with onset 03Mar2021, outcome "recovered" (2021), described as "Headache"; CHILLS (non-serious) with onset 03Mar2021, outcome "recovered" (2021), described as "Chills". Therapeutic measures were taken as a result of cough.  Additional information: patient who have received two doses of the Pfizer's COVID-19 vaccine wants to know if she can receive the booster dose, she had some long term side effects from a COVID infection, she did have the side effects prior to receiving the Pfizer's COVID-19 vaccine.  No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Headache; Chills; I got so sick for 3-4 days; I threw up; I stilll have some cough; I still have some difficulty with endurance; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101409427 (Pfizer).  A 54 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 03Mar2021 (Lot number: EN6205) at the age of 54 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: 2020 (ongoing), notes: 2 scares for 4 days in Jun-Jul 2020. Fever, Chills, monstrous Headache, phlegmy cough, Rapid heart rate, Zero endurance Unable to walk 1o w/o losing breath. I used glutathione with black current syrup calcium , magnesium, with zinc, echinacea. Concomitant medication(s) included: GLUTATHIONE taken for covid-19; VITAMIN D NOS, start date: 2014 (ongoing). Vaccination history included: Bnt162b2 (First dose, Anatomical location: Upper Left arm, Lot number: Pfizer EN6201), administration date: 12Feb2021, when the patient was 54 years old, for COVID-19 immunization. The following information was reported: ILLNESS (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "I got so sick for 3-4 days"; VOMITING (non-serious) with onset 2021, outcome "unknown", described as "I threw up"; COUGH (non-serious) with onset 2021, outcome "not recovered", described as "I stilll have some cough"; ASTHENIA (non-serious) with onset 2021, outcome "unknown", described as "I still have some difficulty with endurance"; HEADACHE (non-serious) with onset 03Mar2021, outcome "recovered" (2021), described as "Headache"; CHILLS (non-serious) with onset 03Mar2021, outcome "recovered" (2021), described as "Chills". Therapeutic measures were taken as a result of cough.  Additional information: patient who have received two doses of the Pfizer's COVID-19 vaccine wants to know if she can receive the booster dose, she had some long term side effects from a COVID infection, she did have the side effects prior to receiving the Pfizer's COVID-19 vaccine.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Inflammation, Movement disorder, Myalgia
Clinical narrative: July / August/ September extreme muscle & joint pain.; July / August/ September extreme muscle & joint pain.; Disturbing my sleep patterns; Unable to move my arms / legs due to inflammation.; Unable to move my arms / legs due to inflammation.; neck upper back muscle pain; neck upper back muscle pain; neck upper back muscle pain; Minimal joint pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date Mar2021 (Lot number: ER8729) at the age of 55 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer, lot number=EP6955, lot unknown=False, administration date=Mar2021, administration time=11:00 AM, dose number=1, vaccine location=Left arm), administration date: Mar2021, when the patient was 55 years old, for COVID-19 immunisation. The following information was reported: NECK PAIN (non-serious), MYALGIA (non-serious), BACK PAIN (non-serious) all with onset May2021, outcome "not recovered" and all described as "neck upper back muscle pain"; ARTHRALGIA (non-serious) with onset May2021, outcome "not recovered", described as "Minimal joint pain"; MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset Jul2021, outcome "not recovered" and all described as "July / August/ September extreme muscle & joint pain."; SLEEP DISORDER (non-serious) with onset Jul2021, outcome "not recovered", described as "Disturbing my sleep patterns"; INFLAMMATION (non-serious), MOVEMENT DISORDER (non-serious) all with onset Jul2021, outcome "not recovered" and all described as "Unable to move my arms / legs due to inflammation.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of neck pain, myalgia, arthralgia, myalgia, arthralgia, sleep disorder, inflammation, movement disorder, back pain.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Case was reported as non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.    No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, SARS-CoV-2 test, Sleep disorder
Clinical narrative: July / August/ September extreme muscle & joint pain.; July / August/ September extreme muscle & joint pain.; Disturbing my sleep patterns; Unable to move my arms / legs due to inflammation.; Unable to move my arms / legs due to inflammation.; neck upper back muscle pain; neck upper back muscle pain; neck upper back muscle pain; Minimal joint pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date Mar2021 (Lot number: ER8729) at the age of 55 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer, lot number=EP6955, lot unknown=False, administration date=Mar2021, administration time=11:00 AM, dose number=1, vaccine location=Left arm), administration date: Mar2021, when the patient was 55 years old, for COVID-19 immunisation. The following information was reported: NECK PAIN (non-serious), MYALGIA (non-serious), BACK PAIN (non-serious) all with onset May2021, outcome "not recovered" and all described as "neck upper back muscle pain"; ARTHRALGIA (non-serious) with onset May2021, outcome "not recovered", described as "Minimal joint pain"; MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset Jul2021, outcome "not recovered" and all described as "July / August/ September extreme muscle & joint pain."; SLEEP DISORDER (non-serious) with onset Jul2021, outcome "not recovered", described as "Disturbing my sleep patterns"; INFLAMMATION (non-serious), MOVEMENT DISORDER (non-serious) all with onset Jul2021, outcome "not recovered" and all described as "Unable to move my arms / legs due to inflammation.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of neck pain, myalgia, arthralgia, myalgia, arthralgia, sleep disorder, inflammation, movement disorder, back pain.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Case was reported as non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.    No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Lymphadenopathy, Nausea, Pyrexia
Clinical narrative: doesn't feel good; fever; nausea; feels lightheaded; feels generally crappy; has some swollen glands; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 66 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 19Sep2021 (Lot number: FC3184, Expiration Date: 31Oct2021) at the age of 66 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Breast cancer" (unspecified if ongoing), notes: Diagnosed 3-4 years ago. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1,SINGLE, Lot Number: FC3181, Anatomical Location:  Injection; Right Arm), administration date: 29Aug2021, when the patient was 66 years old, for Covid-19 immunization. The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "doesn't feel good"; PYREXIA (non-serious) with onset 20Sep2021, outcome "not recovered", described as "fever"; NAUSEA (non-serious) with onset 20Sep2021, outcome "not recovered", described as "nausea"; DIZZINESS (non-serious) with onset 20Sep2021, outcome "not recovered", described as "feels lightheaded"; FEELING ABNORMAL (non-serious) with onset 20Sep2021, outcome "not recovered", described as "feels generally crappy"; LYMPHADENOPATHY (non-serious) with onset 20Sep2021, outcome "not recovered", described as "has some swollen glands".  Additional information: Prior vaccination (within 4 weeks) no any other vaccine administrated. Adverse event prior vaccination was none.   No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature abnormal, Chills, Fatigue, Headache
Clinical narrative: This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient. A 51 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 19Sep2021 12:15 (Lot number: FC3184) at the age of 51 years as dose 2, single for Covid-19 immunisation. Relevant medical history included: "High cholesterol" (unspecified if ongoing); "Covid" (unspecified if ongoing), notes: if Covid-19 prior vaccination: Yes. Concomitant medication(s) included: Atorvastatin. Vaccination history included: Bnt162b2 (Product: COVID 19, Brand: Pfizer, Lot number: FC3181, Administration time=12:45 PM, vaccine location=Right arm, Dose number:1), administration date: 29Aug2021, when the patient was 51 years old, for Covid-19 Immunization. The following information was reported: PARAESTHESIA (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Tingling in hands and feet"; BODY TEMPERATURE ABNORMAL (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Temperature"; CHILLS (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "chills"; NAUSEA (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Nausea"; VOMITING (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "vomiting"; PAIN (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Body aches"; VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 19Sep2021 22:00, outcome "not recovered" and all described as "Injection site redness and pain"; HEADACHE (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Headache"; FATIGUE (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Tiredness"; MYALGIA (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Muscle pain"; ARTHRALGIA (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Joint pain"; MALAISE (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Feeling unwell"; PAIN IN EXTREMITY (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Right arm pain". Therapeutic measures were not taken as a result of paraesthesia, body temperature abnormal, chills, nausea, vomiting, pain, vaccination site erythema, vaccination site pain, headache, fatigue, myalgia, arthralgia, malaise, pain in extremity. No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Nausea, Pain, Pain in extremity
Clinical narrative: This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient. A 51 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 19Sep2021 12:15 (Lot number: FC3184) at the age of 51 years as dose 2, single for Covid-19 immunisation. Relevant medical history included: "High cholesterol" (unspecified if ongoing); "Covid" (unspecified if ongoing), notes: if Covid-19 prior vaccination: Yes. Concomitant medication(s) included: Atorvastatin. Vaccination history included: Bnt162b2 (Product: COVID 19, Brand: Pfizer, Lot number: FC3181, Administration time=12:45 PM, vaccine location=Right arm, Dose number:1), administration date: 29Aug2021, when the patient was 51 years old, for Covid-19 Immunization. The following information was reported: PARAESTHESIA (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Tingling in hands and feet"; BODY TEMPERATURE ABNORMAL (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Temperature"; CHILLS (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "chills"; NAUSEA (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Nausea"; VOMITING (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "vomiting"; PAIN (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Body aches"; VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 19Sep2021 22:00, outcome "not recovered" and all described as "Injection site redness and pain"; HEADACHE (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Headache"; FATIGUE (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Tiredness"; MYALGIA (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Muscle pain"; ARTHRALGIA (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Joint pain"; MALAISE (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Feeling unwell"; PAIN IN EXTREMITY (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Right arm pain". Therapeutic measures were not taken as a result of paraesthesia, body temperature abnormal, chills, nausea, vomiting, pain, vaccination site erythema, vaccination site pain, headache, fatigue, myalgia, arthralgia, malaise, pain in extremity. No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Vaccination site erythema, Vaccination site pain, Vomiting
Clinical narrative: This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient. A 51 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 19Sep2021 12:15 (Lot number: FC3184) at the age of 51 years as dose 2, single for Covid-19 immunisation. Relevant medical history included: "High cholesterol" (unspecified if ongoing); "Covid" (unspecified if ongoing), notes: if Covid-19 prior vaccination: Yes. Concomitant medication(s) included: Atorvastatin. Vaccination history included: Bnt162b2 (Product: COVID 19, Brand: Pfizer, Lot number: FC3181, Administration time=12:45 PM, vaccine location=Right arm, Dose number:1), administration date: 29Aug2021, when the patient was 51 years old, for Covid-19 Immunization. The following information was reported: PARAESTHESIA (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Tingling in hands and feet"; BODY TEMPERATURE ABNORMAL (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Temperature"; CHILLS (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "chills"; NAUSEA (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Nausea"; VOMITING (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "vomiting"; PAIN (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Body aches"; VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 19Sep2021 22:00, outcome "not recovered" and all described as "Injection site redness and pain"; HEADACHE (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Headache"; FATIGUE (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Tiredness"; MYALGIA (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Muscle pain"; ARTHRALGIA (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Joint pain"; MALAISE (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Feeling unwell"; PAIN IN EXTREMITY (non-serious) with onset 19Sep2021 22:00, outcome "not recovered", described as "Right arm pain". Therapeutic measures were not taken as a result of paraesthesia, body temperature abnormal, chills, nausea, vomiting, pain, vaccination site erythema, vaccination site pain, headache, fatigue, myalgia, arthralgia, malaise, pain in extremity. No follow-up attempts are possible. No further information is expected.